/dna-to-rna/articles/rss en /dna-to-rna/article/defining-genetic-discrimination-toward-equity-healthcare-and-research <p>We had a chance to sit down with Yann Joly, James ���ϲ����� Professor in the department of Human Genetics and a member of D2R’s Partner and Community Engagement Committee <a href="#Footnote1">[1]</a> to discuss his report titled <i>“A proposal for an inclusive working definition of genetic discrimination to promote a more coherent debate</i>” recently published in Nature Genetics. He shared insights into the proposed definition of genetic discrimination, its impact on healthcare, and recommendations for its consideration in research, particularly within D2R.</p> Tue, 25 Jun 2024 20:03:15 +0000 Emily Cholette 959 at /dna-to-rna /dna-to-rna/article/honoring-legacy-jerry-pelletier-symposium-rna-therapeutics <p>On May 3<sup>rd</sup>, 2024, more than 200 professors, trainees, former colleagues, mentors, friends and family gathered from near and afar to commemorate the legacy of Professor Jerry Pelletier, a scientist whose outstanding contributions to the field of RNA biology, therapeutics, and cancer research continue to inspire. Pelletier’s profound impact on those who had the privilege of knowing him was evident throughout the event, as speakers and colleagues shared anecdotes and insights into his life and work.</p> Mon, 13 May 2024 17:44:08 +0000 Emily Cholette 919 at /dna-to-rna /dna-to-rna/article/insights-tokyo-symposium-bridging-science-and-collaboration <p>“<i>If you have an apple and I have an apple and we exchange these apples then you and I will still each have one apple. But if you have an idea and I have an idea and we exchange these ideas, then each of us will have two ideas.”</i> George Bernard Shaw (Irish playwright)</p> Thu, 09 May 2024 14:18:17 +0000 Emily Cholette 912 at /dna-to-rna /dna-to-rna/article/nanocore-unlocking-power-nanomedicine <p>Imagine a scenario where a child is unable to produce a vital protein in the liver, threatening their life within a year. Now imagine that through utilizing genomic technologies, researchers can quickly identify the deficient protein, synthesize messenger RNA (mRNA) within months, and encapsulate it into nanoparticles within a day. The result? A customized life-saving medicine tailored to the child's specific needs. This groundbreaking application shows the transformative potential of nanomedicines.</p> Thu, 09 May 2024 14:03:20 +0000 Emily Cholette 911 at /dna-to-rna /dna-to-rna/article/exploring-mcgills-history-rna-research <p>The D2R Initiative leverages ���ϲ�����’s decades-long expertise in DNA and RNA research to develop the next generation of RNA medicines.</p> <p>���ϲ����� researchers have been uncovering the mechanisms and potential of RNA for over 50 years. From genomics and RNA biology to medicine and biomanufacturing, these research strengths cover the range of expertise needed to discover gene targets and develop new treatments for disease.</p> Tue, 16 Apr 2024 21:08:50 +0000 D2R 890 at /dna-to-rna /dna-to-rna/article/collaboration-between-universities-public-sector-and-private-sector-key-driver-progress The rapid development of mRNA vaccines against SARS-CoV-2 – vaccines that drew on earlier mRNA research – testified to what can be accomplished when the world’s scientists put their minds together, with industry and governments investing to accelerate progress. Fri, 29 Mar 2024 19:53:51 +0000 Martha Crago 638 at /dna-to-rna